Skip to main content
. 2021 Feb 10;8(2):126. doi: 10.3390/children8020126

Table 1.

Cases of relapse of neonatal Echerichia coli meningitis.

Case First E. coli Meningitis Relapse E. coli Meningitis Follow-Up
Sex GA
at birth
(weeks)
BW
(gram)
Age
(days)
Treatment Cerebral MRI Urinary ultra-sound Time from completion (days) Treatment Age
(years)
Under-lying disease Sequelae *
1 F 36 + 3 2130 3 Cefotaxime 21 days + gentamicin
day 1–5
Minor hemorrhagic parenchymal infarctions.
No signs of infection.
(without contrast)
Normal 4 Meropenem 1 week followed by
ceftriaxone 9 weeks
4.0 No No
2 M 34 + 0 1980 5 Cefotaxime 21 days + gentamicin
day 1–3
Normal
(with contrast)
Normal 11 Cefotaxime 1 week, meropenem 1 week followed by
ceftriaxone 12 weeks
3.5 No No
3 M 34 + 5 2280 45 Cefotaxime 20 days + gentamicin
day 1–7
Ischemic changes of cortical parenchyma.
No signs of infection.
(without contrast)
Normal 28 Ceftriaxone 8 weeks 3.5 No Moderate sensory disabilities, visual impairment, delayed development.
No signs of hydrocephalus or cerebral palsy. Persistent changes on MRI.
4 F 37 + 1 2940 13 Cefotaxime 22 days + gentamicin
day 1–3
Minor hemorrhagic parenchymal infarctions.
No signs of infection.
(without contrast)
Normal 2 Meropenem
+ ciprofloxacin 6 weeks followed by
ceftriaxone 3 weeks
4.0 No No

F = Female; M = Male; GA = Gestational Age; BW = Birth Weight; MRI = Magnetic Resonance Imaging. * Developmental milestones and audiology were investigated, in addition to signs of cerebral palsy and hydrocephalus.